{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:41:06Z","timestamp":1780098066278,"version":"3.54.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1186\/1471-2105-7-s2-s20","type":"journal-article","created":{"date-parts":[[2006,9,26]],"date-time":"2006-09-26T18:28:57Z","timestamp":1159295337000},"source":"Crossref","is-referenced-by-count":45,"title":["Gene Expression Profiles Distinguish the Carcinogenic Effects of Aristolochic Acid in Target (Kidney) and Non-target (Liver) Tissues in Rats"],"prefix":"10.1186","volume":"7","author":[{"given":"Tao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C","family":"Fuscoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,9,26]]},"reference":[{"issue":"4","key":"1314_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/mutage\/17.4.265","volume":"17","author":"VM Arlt","year":"2002","unstructured":"Arlt VM, Stiborova M, Schmeiser HH: Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002, 17(4):265\u2013277. 10.1093\/mutage\/17.4.265","journal-title":"Mutagenesis"},{"issue":"8842","key":"1314_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0140-6736(93)92984-2","volume":"341","author":"JL Vanherweghem","year":"1993","unstructured":"Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhaelen-Fastre R, et al.: Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993, 341(8842):387\u2013391. 10.1016\/0140-6736(93)92984-2","journal-title":"Lancet"},{"issue":"6","key":"1314_CR3","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/ki.1994.220","volume":"45","author":"JP Cosyns","year":"1994","unstructured":"Cosyns JP, Jadoul M, Squifflet JP, De Plaen JF, Ferluga D, van Ypersele de Strihou C: Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int 1994, 45(6):1680\u20131688.","journal-title":"Kidney Int"},{"issue":"2","key":"1314_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0272-6386(12)80178-8","volume":"24","author":"M Depierreux","year":"1994","unstructured":"Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL: Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 1994, 24(2):172\u2013180.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1314_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/acm.1998.4.1-9","volume":"4","author":"LJ Vanherweghem","year":"1998","unstructured":"Vanherweghem LJ: Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med 1998, 4(1):9\u201313.","journal-title":"J Altern Complement Med"},{"issue":"8890","key":"1314_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0140-6736(94)90964-4","volume":"343","author":"M Vanhaelen","year":"1994","unstructured":"Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem JL: Identification of aristolochic acid in Chinese herbs. Lancet 1994, 343(8890):174. 10.1016\/S0140-6736(94)90964-4","journal-title":"Lancet"},{"issue":"23","key":"1314_CR7","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","volume":"342","author":"JL Nortier","year":"2000","unstructured":"Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, et al.: Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000, 342(23):1686\u20131692. 10.1056\/NEJM200006083422301","journal-title":"N Engl J Med"},{"issue":"2","key":"1314_CR8","first-page":"270","volume":"10","author":"JL Vanherweghem","year":"1995","unstructured":"Vanherweghem JL, Tielemans C, Simon J, Depierreux M: Chinese herbs nephropathy and renal pelvic carcinoma. Nephrol Dial Transplant 1995, 10(2):270\u2013273.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"1314_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/BF00295084","volume":"59","author":"U Mengs","year":"1987","unstructured":"Mengs U: Acute toxicity of aristolochic acid in rodents. Arch Toxicol 1987, 59(5):328\u2013331. 10.1007\/BF00295084","journal-title":"Arch Toxicol"},{"issue":"6","key":"1314_CR10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/BF00293699","volume":"61","author":"U Mengs","year":"1988","unstructured":"Mengs U: Tumour induction in mice following exposure to aristolochic acid. Arch Toxicol 1988, 61(6):504\u2013505. 10.1007\/BF00293699","journal-title":"Arch Toxicol"},{"key":"1314_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF00302751","volume":"51","author":"U Mengs","year":"1982","unstructured":"Mengs U, Lang W, Poch I: The crcinogenic action of aristolochic acid in rats. Arch Toxicol 1982, 51: 107\u2013119. 10.1007\/BF00302751","journal-title":"Arch Toxicol"},{"issue":"3","key":"1314_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/BF00333900","volume":"52","author":"U Mengs","year":"1983","unstructured":"Mengs U: On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid. Arch Toxicol 1983, 52(3):209\u2013220. 10.1007\/BF00333900","journal-title":"Arch Toxicol"},{"key":"1314_CR13","unstructured":"Gold L, Zeiger E, (eds): Handbook of carcinogenic potency and genotoxicity databases. Boca Raton, Fla CRC Press; 1997. [\n                    http:\/\/potency.berkeley.edu\/\n                    \n                  ]"},{"key":"1314_CR14","volume-title":"IARC monographs on the evaluation of carcinogenic risk of chemicals to humans","author":"IARC","year":"2002","unstructured":"IARC: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. In IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. Volume 82. Lyons, France: IARC Press; 2002."},{"issue":"21","key":"1314_CR15","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1001\/jama.285.21.2705-JFD10005-2-1","volume":"285","author":"BA Schwetz","year":"2001","unstructured":"Schwetz BA: From the Food and Drug Administration. Jama 2001, 285(21):2705. [\n                    http:\/\/www.cfsan.fda.gov\/~dms\/ds-bot.html\n                    \n                  ] 10.1001\/jama.285.21.2705","journal-title":"Jama"},{"issue":"16","key":"1314_CR16","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJM200310163491619","volume":"349","author":"LS Gold","year":"2003","unstructured":"Gold LS, Slone TH: Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert. N Engl J Med 2003, 349(16):1576\u20131577. 10.1056\/NEJM200310163491619","journal-title":"N Engl J Med"},{"issue":"2","key":"1314_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ijc.20564","volume":"113","author":"M Stiborova","year":"2005","unstructured":"Stiborova M, Frei E, Hodek P, Wiessler M, Schmeiser HH: Human hepatic and renal microsomes, cytochromes P450 1A1\/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer. Int J Cancer 2005, 113(2):189\u2013197. 10.1002\/ijc.20564","journal-title":"Int J Cancer"},{"key":"1314_CR18","first-page":"167","volume":"124","author":"RC Fernando","year":"1993","unstructured":"Fernando RC, Schmeiser HH, Scherf HR, Wiessler M: Formation and persistence of specific purine DNA adducts by \n                    32\n                  P-postlabelling in target and non-target organs of rats treated with aristolochic acid I. IARC Sci Publ 1993, 124: 167\u2013171.","journal-title":"IARC Sci Publ"},{"issue":"9","key":"1314_CR19","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/carcin\/11.9.1627","volume":"11","author":"W Pfau","year":"1990","unstructured":"Pfau W, Schmeiser HH, Wiessler M: 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II. Carcinogenesis 1990, 11(9):1627\u20131633.","journal-title":"Carcinogenesis"},{"issue":"1","key":"1314_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/carcin\/7.1.59","volume":"7","author":"HH Schmeiser","year":"1986","unstructured":"Schmeiser HH, Pool BL, Wiessler M: Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver. Carcinogenesis 1986, 7(1):59\u201363.","journal-title":"Carcinogenesis"},{"issue":"13","key":"1314_CR21","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1002\/sim.2082","volume":"24","author":"A Wang","year":"2005","unstructured":"Wang A, Gehan EA: Gene selection for microarray data analysis using principal component analysis. Stat Med 2005, 24(13):2069\u20132087. 10.1002\/sim.2082","journal-title":"Stat Med"},{"issue":"Database","key":"1314_CR22","first-page":"D258","volume":"32","author":"MA Harris","year":"2004","unstructured":"Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C, et al.: The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 2004, 32(Database):D258\u2013261.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1314_CR23","first-page":"301","volume":"36","author":"Z Su","year":"2002","unstructured":"Su Z, Xu S, Zheng F, Li Y: [Aristolochic acid induced transdifferentiation and apoptosis in human tubular epithelial cells in vitro]. Zhonghua Yu Fang Yi Xue Za Zhi 2002, 36(5):301\u2013304.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"5","key":"1314_CR24","first-page":"418","volume":"113","author":"R Gao","year":"2000","unstructured":"Gao R, Zheng F, Liu Y, Zheng D, Li X, Bo Y: Aristolochic acid I-induced apoptosis in LLC-PK1 cells and amelioration of the apoptotic damage by calcium antagonist. Chin Med J (Engl) 2000, 113(5):418\u2013424.","journal-title":"Chin Med J (Engl)"},{"issue":"1\u20132","key":"1314_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0006-8993(98)00879-8","volume":"811","author":"CP Fall","year":"1998","unstructured":"Fall CP, Bennett JP Jr: MPP+ induced SH-SY5Y apoptosis is potentiated by cyclosporin A and inhibited by aristolochic acid. Brain Res 1998, 811(1\u20132):143\u2013146. 10.1016\/S0006-8993(98)00879-8","journal-title":"Brain Res"},{"issue":"3","key":"1314_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10157-003-0229-z","volume":"7","author":"MC Liu","year":"2003","unstructured":"Liu MC, Maruyama S, Mizuno M, Morita Y, Hanaki S, Yuzawa Y, Matsuo S: The nephrotoxicity of Aristolochia manshuriensis in rats is attributable to its aristolochic acids. Clin Exp Nephrol 2003, 7(3):186\u2013194. 10.1007\/s10157-003-0229-z","journal-title":"Clin Exp Nephrol"},{"key":"1314_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1101\/SQB.1994.059.01.044","volume":"59","author":"E White","year":"1994","unstructured":"White E, Chiou SK, Rao L, Sabbatini P, Lin HJ: Control of p53-dependent apoptosis by E1B, Bcl-2, and Ha-ras proteins. Cold Spring Harb Symp Quant Biol 1994, 59: 395\u2013402.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"1","key":"1314_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.ki.5000029","volume":"69","author":"BM Hendry","year":"2006","unstructured":"Hendry BM, Khwaja A, Qu QY, Shankland SJ: Distinct functions for Ras GTPases in the control of proliferation and apoptosis in mouse and human mesangial cells. Kidney Int 2006, 69(1):99\u2013104. 10.1038\/sj.ki.5000029","journal-title":"Kidney Int"},{"issue":"3","key":"1314_CR29","first-page":"887","volume":"62","author":"HJ Varghese","year":"2002","unstructured":"Varghese HJ, Davidson MT, MacDonald IC, Wilson SM, Nadkarni KV, Groom AC, Chambers AF: Activated ras regulates the proliferation\/apoptosis balance and early survival of developing micrometastases. Cancer Res 2002, 62(3):887\u2013891.","journal-title":"Cancer Res"},{"issue":"6","key":"1314_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1634\/stemcells.20-6-493","volume":"20","author":"Y Shav-Tal","year":"2002","unstructured":"Shav-Tal Y, Zipori D: The role of activin a in regulation of hemopoiesis. Stem Cells 2002, 20(6):493\u2013500. 10.1634\/stemcells.20-6-493","journal-title":"Stem Cells"},{"issue":"4","key":"1314_CR31","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/pr050404w","volume":"5","author":"M Chen","year":"2006","unstructured":"Chen M, Su M, Zhao L, Jiang J, Liu P, Cheng J, Lai Y, Liu Y, Jia W: Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. J Proteome Res 2006, 5(4):995\u20131002. 10.1021\/pr050404w","journal-title":"J Proteome Res"},{"issue":"15","key":"1314_CR32","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1289\/ehp.6497","volume":"111","author":"W Tong","year":"2003","unstructured":"Tong W, Cao X, Harris S, Sun H, Fang H, Fuscoe J, Harris A, Hong H, Xie Q, Perkins R, et al.: ArrayTrack \u2013 supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect 2003, 111(15):1819\u20131826.","journal-title":"Environ Health Perspect"},{"issue":"9","key":"1314_CR33","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98(9):5116\u20135121. 10.1073\/pnas.091062498","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"1314_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.mrfmmm.2003.12.024","volume":"549","author":"W Tong","year":"2004","unstructured":"Tong W, Harris S, Cao X, Fang H, Shi L, Sun H, Fuscoe J, Harris A, Hong H, Xie Q, et al.: Development of public toxicogenomics software for microarray data management and analysis. Mutat Res 2004, 549(1\u20132):241\u2013253. [\n                    http:\/\/www.fda.gov\/nctr\/science\/centers\/toxicoinformatics\/ArrayTrack\/\n                    \n                  ]","journal-title":"Mutat Res"},{"key":"1314_CR35","unstructured":"IPA2006. [\n                    http:\/\/www.ingenuity.com\n                    \n                  ]"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-7-S2-S20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2105-7-S2-S20\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-7-S2-S20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:35:40Z","timestamp":1548117340000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-7-S2-S20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":35,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["1314"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-7-s2-s20","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]},"article-number":"S20"}}